A subgroup of anal cancer patients expressed PD-L1 on the tumor cells, as reported in previous reports [20,21,22] and, interestingly, this was also the case in almost two-thirds of the patients in our study population, indicating that these tumors might be susceptible to ICB. The gene discussed is CD274; the disease is anal carcinoma.